Home › NCT06662357
Family Connections
Family Connections: A Community-Based Approach to Expanding Mental Health Access and Engagement for SED Youth
Who can join
Ages 3 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * 3 through 18 years (17½ years maximum at time of enrollment) * Referred by Primary Care Physician's (PCP) from one of the three Cambridge Health Alliance (CHA) primary care intervention sites to the Family Connections team for an integrated child mental health and/or substance use disorder clinical assessment. * Positive screen on CHA's standard pediatric mental health and substance use screening instruments, and/or parental concern about possible mental health/substance use needs, and/or PCP concern about possible mental health/substance use needs * Enrolled in MassHealth Exclusion Criteria: * Subjects over 17.5 years (SAMHSA data collection required at 6 and 12 months after enrollment which must occur before age 18 years.) * Youth who are not enrolled in MassHealth * CHA patients with PCP located at CHA primary care site other than the identified intervention sites
About the study
The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. This clinical innovation, nested in an integrated system-of-care will be piloted for children, ages 3-18 yrs., with SED who receive primary care through Cambridge Health Alliance.
What is being tested
- Behavioral Treatment (behavioral)
Sponsor: Cambridge Health Alliance · Participants: 300 · Started: Jan 30, 2025
Contact the study team
- Katherine E Grimes, MD, MPH · Phone: 617-806-8718
- Program Administrator, MPH · Phone: 857-260-2867
Official record on ClinicalTrials.gov — NCT06662357
Locations in the U.S.
| Massachusetts | Cambridge Health Alliance, Cambridge |
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.